Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
24/07/2023 17:33
July 24 (Reuters) - Epigenomics Ag ECX1k.DE :
* EQS-ADHOC: EPIGENOMICS AG: AGREEMENT ON THE ACQUISITION OF
ALMOST ALL ASSETS
* COMPANY RECEIVES A PURCHASE PRICE OF UP TO USD 12.05
MILLION
* UNDER DEAL COMPANY UNDERTAKES IN PARTICULAR TO TRANSFER
ALL ITS
PATENTS AS WELL AS ITS ENTIRE BIOBANK TO ACQUIRER
* IN ADDITION, COMPANY RECEIVES LICENSE PAYMENTS AND
EARN-OUT
PAYMENTS (MAINLY IN FORM OF ROYALTIES ON SALES)
Source text for Eikon: ID:nEQ25lcJxa
Further company coverage: ECX1k.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns